3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9512169
APP PUB NO 20150210734A1
SERIAL NO

14414386

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to AKR1C3 inhibitors and to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular bleeding disorders and endometriosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAYER PHARMA AKTIENGESELLSCHAFTMÜLLERSTR 178 BERLIN 13353

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Barak, Naomi Berlin, DE 12 2
Bothe, Ulrich Berlin, DE 38 212
Busemann, Matthias Berlin, DE 5 3
Fischer, Oliver Martin Berlin, DE 15 23
Marquardt, Tobias Wuppertal, DE 38 77
Rotgeri, Andrea Berlin, DE 40 270
Stegmann, Christian Berlin, DE 25 94

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 6, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00